Grum C M, Gross T J, Mody C H, Sitrin R G
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0360.
J Lab Clin Med. 1990 Aug;116(2):211-8.
The enzyme xanthine oxidase participates in the pathogenesis of tissue ischemia-reperfusion injury by depleting purine pools and generating toxic oxygen metabolites. The role of xanthine oxidase in inflammatory cell populations has not been defined. We examined the level of xanthine oxidase activity expressed by murine leukocytes both in the resting state, and after in vivo and in vitro exposure to inflammatory stimuli. The contribution of xanthine oxidase to inflammation may vary among tissue compartments, so leukocytes harvested from several tissues were studied. Resident murine peritoneal macrophages consistently expressed xanthine oxidase activity (291 +/- 55 microIU/10(6) cells). Thioglycolate-elicited peritoneal macrophages contained similar levels of xanthine oxidase activity (265 +/- 42 microIU/10(6) cells). By contrast, resident murine alveolar macrophages expressed one tenth the xanthine oxidase activity (24 +/- 4 microIU/10(6) cells). Xanthine oxidase activity was also consistently found in murine peritoneal neutrophils (127 +/- 28 microIU/10(6) cells) but not in splenic lymphocytes. In vitro studies were performed to determine whether xanthine oxidase activity of resident peritoneal macrophages could be modulated by exogenous stimuli relevant to the pathogenesis of inflammation. Lipopolysaccharide caused a 62% +/- 9% reduction in cellular xanthine oxidase activity (p less than 0.02). Interferon-gamma alone had no effect on xanthine oxidase activity; however, interferon-gamma and lipopolysaccharide together caused a striking reduction in cellular xanthine oxidase activity, reaching 25% +/- 2% of unstimulated control cells (p less than 0.001). We conclude that murine macrophages and neutrophils are potentially important sources of xanthine oxidase activity in inflamed tissues. In addition, the activity of xanthine oxidase in macrophages is tissue specific and is modulated in vitro by proinflammatory stimuli.
黄嘌呤氧化酶通过消耗嘌呤库和产生活性氧代谢产物参与组织缺血-再灌注损伤的发病机制。黄嘌呤氧化酶在炎症细胞群体中的作用尚未明确。我们检测了静息状态下以及体内和体外暴露于炎症刺激后小鼠白细胞表达的黄嘌呤氧化酶活性水平。由于黄嘌呤氧化酶对炎症的作用可能因组织部位而异,因此我们研究了从多个组织中分离的白细胞。常驻小鼠腹腔巨噬细胞持续表达黄嘌呤氧化酶活性(291±55微国际单位/10⁶个细胞)。巯基乙酸盐诱导的腹腔巨噬细胞含有相似水平的黄嘌呤氧化酶活性(265±42微国际单位/10⁶个细胞)。相比之下,常驻小鼠肺泡巨噬细胞表达的黄嘌呤氧化酶活性仅为前者的十分之一(24±4微国际单位/10⁶个细胞)。在小鼠腹腔中性粒细胞中也持续检测到黄嘌呤氧化酶活性(127±28微国际单位/10⁶个细胞),但在脾淋巴细胞中未检测到。进行体外研究以确定常驻腹腔巨噬细胞的黄嘌呤氧化酶活性是否可被与炎症发病机制相关的外源性刺激所调节。脂多糖使细胞黄嘌呤氧化酶活性降低62%±9%(p<0.02)。单独的干扰素-γ对黄嘌呤氧化酶活性无影响;然而,干扰素-γ和脂多糖共同作用导致细胞黄嘌呤氧化酶活性显著降低,降至未刺激对照细胞的25%±2%(p<0.001)。我们得出结论,小鼠巨噬细胞和中性粒细胞可能是炎症组织中黄嘌呤氧化酶活性的重要潜在来源。此外,巨噬细胞中黄嘌呤氧化酶的活性具有组织特异性,并在体外受到促炎刺激的调节。